Perioperative anticoagulation management during thoracoscopic ablation
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F17%3A43912502" target="_blank" >RIV/00216208:11120/17:43912502 - isvavai.cz</a>
Alternative codes found
RIV/00064173:_____/17:N0000005
Result on the web
<a href="http://dx.doi.org/10.1016/j.hrthm.2016.11.028" target="_blank" >http://dx.doi.org/10.1016/j.hrthm.2016.11.028</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.hrthm.2016.11.028" target="_blank" >10.1016/j.hrthm.2016.11.028</a>
Alternative languages
Result language
angličtina
Original language name
Perioperative anticoagulation management during thoracoscopic ablation
Original language description
With interest we read the article by Romanov et al in the September issue of HeartRhythm.1 They reported that 6 strokes/ transient ischemic attacks (TIAs) occurred perioperatively: 4 (4.5%) in patients undergoing thoracoscopic pulmonary vein isolation þ box lesion only and 2 (2.2%) in patients who underwent an additional occlusion of the left atrial appendage (LAA).1 The exact peri- and postoperative anticoagulation protocol was not reported. Compared with other articles on thoracoscopic ablation (TA) or hybrid ablation, the absence of a description of the peri- and postoperative anticoagulation stands out in this article. In our recent report, 1 stroke and 5 asymptomatic thrombi occurred in 17 patients who underwent TA without heparin and without LAA occlusion, but no strokes or asymptomatic thrombi occurred while on heparin and if the LAA was occluded.2 Compared with endocardial catheter ablation, the risk of stroke/TIA seems to be higher during TA; for example, Probst et al 3 reported 5.1%strokes/TIAs. Therefore, one would expect precise reporting of anticoagulation used perioperatively to address this issue. Unfortunately, the opposite seems to be true; clear description of peri- and postoperative anticoagulation management is obviously lacking.1,3 This is in stark contrast to articles on catheter ablation, in which the anticoagulation protocol is described in detail. In articles on TA, typically the only anticoagulation information given is with regard to withdrawal of warfarin or novel oral anticoagulants before ablation.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Heart Rhythm
ISSN
1547-5271
e-ISSN
—
Volume of the periodical
14
Issue of the periodical within the volume
3
Country of publishing house
US - UNITED STATES
Number of pages
1
Pages from-to
"e47"
UT code for WoS article
000397243700001
EID of the result in the Scopus database
2-s2.0-85007564336